RedHill Biopharma Ltd. (RDHL)

6.28
0.05 0.80
NASDAQ : Health Technology
Prev Close 6.23
Open 6.37
Day Low/High 6.02 / 6.37
52 Wk Low/High 4.30 / 11.25
Volume 31.84K
Avg Volume 129.90K
Exchange NASDAQ
Shares Outstanding 21.27M
Market Cap 128.91M
EPS -2.30
P/E Ratio 23.96
Div & Yield N.A. (N.A)

Latest News

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

The Summit, N.J.-based firm said Thursday that it was discontinuing the GED-0301 (mongersen) Phase 3 Revolve study in Crohn's disease and the extension trial.

Biotech Movers: Red Hill Jumps After Securing Rights Sell GERD Treatment

Biotech Movers: Red Hill Jumps After Securing Rights Sell GERD Treatment

A number of biotech-related stocks were down pre-market after announcing plans for public offerings.

TheStreet Quant Rating: D- (Sell)